How many insider declarations has Column Group IV GP, LP filed?

Column Group IV GP, LP has filed 2 public insider declarations with SEC (Form 4).

What is Column Group IV GP, LP's role?

Column Group IV GP, LP's reported role is not specified by the regulator across the filings.

Which companies does Column Group IV GP, LP report trades for?

Column Group IV GP, LP reports trades for Eikon Therapeutics, Inc..

What is Column Group IV GP, LP's declared buy vs sell volume?

Across the available history, declared buys total 889k€ and disposals 0.

← Executives ★ Sign in to follow

CG

Column Group IV GP, LP

·SEC (Form 4)

Eikon Therapeutics, Inc.

0

申报总数

0

公司

€889,173

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Column Group IV GP, LP. Director active across 1 company, notably Eikon Therapeutics, Inc.. In total, 2 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €889k. Activity tracked since 3 September 2026. The latest transaction was filed on 3 September 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Column Group IV GP, LP

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Eikon Therapeutics, Inc. (US)

申报2 总计

▲

Column Group IV GP, LP

10% Owner高管2026年9月3日Eikon Therapeutics, Inc.

US$103万0SEC ↗

89,200 股@ US$11.5588Common StockSEC:0001193125-26-385268:0

标准退出：2026年12月2日 (T+90)

●

Column Group IV GP, LP

高管2026年2月6日Eikon Therapeutics, Inc.

0SEC ↗

1,296,629 股Common StockSEC:0001193125-26-043320:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

CG

Column Group IV GP, LP

·SEC (Form 4)

Eikon Therapeutics, Inc.

0

申报总数

0

公司

€889,173

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Column Group IV GP, LP. Director active across 1 company, notably Eikon Therapeutics, Inc.. In total, 2 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €889k. Activity tracked since 3 September 2026. The latest transaction was filed on 3 September 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.